Sp964
INTERACTION BETWEEN GUT MICROBIOTA, BILE ACIDS METABOLISM AND IBD
Date
May 20, 2024
Presenter
Washington University in St Louis
Tracks
Related Products
Kiron and Kamala Das Symposium — Pathogenesis Driving Cure: Can We Eliminate IBD?
This session will create a link between novel mechanisms of disease and potentially transformative effect on IBD treatment in the future…
MUCOSAL SINGLE-CELL PROFILING OF CROHN’S-LIKE DISEASE OF THE POUCH REVEALS UNIQUE PATHOGENESIS AND THERAPEUTIC TARGETS
BACKGROUND & AIMS: After restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC), a subset of patients develop Crohn’s-like disease of the pouch (CDP), an inflammatory condition that affects both the ileoanal pouch and extra-pouch organs including the pre-po…
Non-Immune Cells in Intestinal Inflammation and Repair
This session will delineate the most recent discoveries in non-immune cells in inflammatory bowel diseases, including the epithelial barrier, fibroblasts and Paneth cells…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
